Associations between Genetic Variants in the Vitamin D Metabolism Pathway and Severity of COVID-19 among UAE Residents

Vitamin D has many effects on cells in the immune system. Many studies have linked low vitamin D status with severity of COVID-19. Genetic variants involved in vitamin D metabolism have been implicated as potential risk factors for severe COVID-19 outcomes. This study investigated how genetic variations in humans affected the clinical presentation of COVID-19. In total, 646 patients with SARS-CoV-2 infection were divided into two groups: noncritical COVID-19 (n = 453; 70.12%) and a critical group (n = 193; 29.87%). Genotype data on the GC, NADSYN1, VDR, and CYP2R1 genes along with data on serum 25-hydroxyvitamin D levels were compiled in patients admitted to a major hospital in the United Arab Emirates between April 2020 and January 2021. We identified 12 single-nucleotide polymorphisms associated with the critical COVID-19 condition: rs59241277, rs113574864, rs182901986, rs60349934, and rs113876500; rs4944076, rs4944997, rs4944998, rs4944979, and rs10898210; and rs11574018 and rs11574024. We report significant associations between genetic determinants of vitamin D metabolism and COVID-19 severity in the UAE population. Further research needed to clarify the mechanism of action against viral infection in vitamin D deficiency. These variants could be used with vaccination to manage the spread of SARS-CoV-2 and could be particularly valuable in populations in which vitamin D deficiency is common.

[1]  E. Cione,et al.  Immunological Response to SARS-CoV-2 Is Sustained by Vitamin D: A Case Presentation of One-Year Follow-Up , 2021, Reports.

[2]  V. Gasic,et al.  Association of Vitamin D, Zinc and Selenium Related Genetic Variants With COVID-19 Disease Severity , 2021, Frontiers in Nutrition.

[3]  B. Mahboub,et al.  COVID-19 Disease Severity and Death in Relation to Vitamin D Status among SARS-CoV-2-Positive UAE Residents , 2021, Nutrients.

[4]  C. Apovian,et al.  Association of Vitamin D Status With Hospital Morbidity and Mortality in Adult Hospitalized Patients With COVID-19 , 2021, Endocrine Practice.

[5]  Yichun Hu,et al.  [Relationship between rs7041 polymorphism of GC gene and serum vitamin D status in Chinese women of childbearing age]. , 2021, Wei sheng yan jiu = Journal of hygiene research.

[6]  C. Wagner,et al.  Evidence Regarding Vitamin D and Risk of COVID-19 and Its Severity , 2020, Nutrients.

[7]  S. Lippman,et al.  Shining Light on the COVID-19 Pandemic: A Vitamin D Receptor Checkpoint in Defense of Unregulated Wound Healing , 2020, Cell Metabolism.

[8]  G. Novelli,et al.  Genetic variants of the human host influencing the coronavirus-associated phenotypes (SARS, MERS and COVID-19): rapid systematic review and field synopsis , 2020, Human genomics.

[9]  R. Bouillon,et al.  “Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study” , 2020, The Journal of Steroid Biochemistry and Molecular Biology.

[10]  Keith Sigel,et al.  An inflammatory cytokine signature predicts COVID-19 severity and survival , 2020, Nature Medicine.

[11]  N. Hekim,et al.  The role of DBP gene polymorphisms in the prevalence of new coronavirus disease 2019 infection and mortality rate , 2020, Journal of medical virology.

[12]  M. Peana,et al.  Micronutrients as immunomodulatory tools for COVID-19 management , 2020, Clinical Immunology.

[13]  J. de Azevêdo Silva,et al.  Mechanism of inflammatory response in associated comorbidities in COVID-19 , 2020, Diabetes & Metabolic Syndrome: Clinical Research & Reviews.

[14]  G. Glinsky.  Tripartite Combination of Candidate Pandemic Mitigation Agents: Vitamin D, Quercetin, and Estradiol Manifest Properties of Medicinal Agents for Targeted Mitigation of the COVID-19 Pandemic Defined by Genomics-Guided Tracing of SARS-CoV-2 Targets in Human Cells , 2020, Biomedicines.

[15]  Iain B McInnes,et al.  Obesity a Risk Factor for Severe COVID-19 Infection: Multiple Potential Mechanisms. , 2020, Circulation.

[16]  W. Grant,et al.  Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths , 2020, Nutrients.

[17]  D. Murdoch,et al.  Clinical course and mortality risk of severe COVID-19 , 2020, The Lancet.

[18]  H. Jelinek,et al.  Implication of Genetic Variants in Overweight and Obesity susceptibility among the Young Arab Population of the United Arab Emirates. , 2020, Gene.

[19]  O. Mäkitie,et al.  Genetic Variation of the Vitamin D Binding Protein Affects Vitamin D Status and Response to Supplementation in Infants. , 2019, The Journal of clinical endocrinology and metabolism.

[20]  E. Cione,et al.  25-Hydroxy Vitamin D Detection Using Different Analytic Methods in Patients with Migraine , 2019, Journal of clinical medicine.

[21]  D. Bikle,et al.  Vitamin D Binding Protein, Total and Free Vitamin D Levels in Different Physiological and Pathophysiological Conditions , 2019, Front. Endocrinol..

[22]  David A. Jolliffe,et al.  Vitamin D receptor genotype influences risk of upper respiratory infection. , 2018, The British journal of nutrition.

[23]  H. Jelinek,et al.  Vitamin D receptor gene polymorphisms among Emirati patients with type 2 diabetes mellitus , 2018, The Journal of Steroid Biochemistry and Molecular Biology.

[24]  F. Moy,et al.  The associations between VDR BsmI polymorphisms and risk of vitamin D deficiency, obesity and insulin resistance in adolescents residing in a tropical country , 2017, PloS one.

[25]  G. Elghazali,et al.  Investigating the Association of Vitamin D Metabolism Genes CYP2R1, CYP24A1 and CYP27B1 with Vitamin D Status in Young Adult Emiratis , 2017 .

[26]  J. Abubaker,et al.  Vitamin D Insufficiency in Arabs and South Asians Positively Associates with Polymorphisms in GC and CYP2R1 Genes , 2014, PloS one.

[27]  J. Little,et al.  Vitamin D receptor (VDR) polymorphisms and severe RSV bronchiolitis: A systematic review and meta‐analysis , 2014, Pediatric pulmonology.

[28]  H. DeLuca,et al.  CYP2R1 is a major, but not exclusive, contributor to 25-hydroxyvitamin D production in vivo , 2013, Proceedings of the National Academy of Sciences.

[29]  M. Holick,et al.  Influence of Vitamin D Status and Vitamin D3 Supplementation on Genome Wide Expression of White Blood Cells: A Randomized Double-Blind Clinical Trial , 2013, PloS one.

[30]  R. Bouillon.  Genetic and environmental determinants of vitamin D status , 2010, The Lancet.

[31]  William Wheeler,et al.  Genome-wide association study of circulating vitamin D levels , 2010, Human molecular genetics.